Filing Details

Accession Number:
0001144204-14-033555
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-05-27 10:25:15
Reporting Period:
2014-05-22
Filing Date:
2014-05-27
Accepted Time:
2014-05-27 09:25:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1426800 Ventrus Biosciences Inc VTUS Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1374805 H Russell Ellison 99 Hudson Street
5Th Floor
New York NY US 10013
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-05-22 5,000 $0.90 30,000 No 4 P Direct
Common Stock Acquisiton 2014-05-23 15,000 $0.91 45,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Stock Options (right to buy) $3.81 2024-01-15 395,500 395,500 Direct
Common Stock Restricted Stock Units $0.00 2016-06-30 200,000 150,000 Direct
Common Stock Phantom Stock $0.00 50,000 50,000 Direct
Common Stock Stock Options (right to buy) $8.10 2022-01-15 60,000 60,000 Direct
Common Stock Stock Options (right to buy) $6.00 2020-12-22 573,599 573,599 Direct
Common Stock Warrants (right to buy) $7.69 2014-11-08 8,065 8,065 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2024-01-15 395,500 395,500 Direct
2016-06-30 200,000 150,000 Direct
50,000 50,000 Direct
2022-01-15 60,000 60,000 Direct
2020-12-22 573,599 573,599 Direct
2014-11-08 8,065 8,065 Direct
Footnotes
  1. The options vest 1/3 on 1/15/2015, and the remaining 2/3 will vest in equal installments on the second and third anniversaries after 1/15/2014.
  2. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
  3. Each restricted stock unit represents a contingent right to receive one share of the The restricted stock units vest in four equal amounts (25% each) as follows: 25% on the date of grant and 25% when the 20 trading day volume weighted average price of the Issuer's common stock equals or exceeds $4.15, $5.15 and $6.15. The unvested restricted stock units expire on June 30, 2016 if a vesting threshold has not been met by that date.
  4. Upon the immediate vesting on April 5, 2013 of 50,000 restricted stock units granted to the reporting person on April 5, 2013, the reporting person elected to defer the receipt of those 50,000 shares of common stock, resulting in the accrual to his phantom stock account of 50,000 shares of phantom stock.
  5. Each share of phantom stock represents the right to receive one share of the Issuer's common stock.
  6. The phantom stock becomes payable on the earliest to occur of (a) termination of employment, (b) a change in control of the Issuer, or (c) April 1, 2015.
  7. The options vested 1/3 on 1/15/2013, and the remaining 2/3 will vest in equal installments on the second and third anniversaries after 1/15/2013.
  8. The options vest 1/3 on 12/22/2010, and the remaining 2/3 will vest in equal installments on the second and third anniversaries after 12/22/2010.
  9. The warrant vested in three installments on 3/21/08 (2,689 shares), 3/21/2009 (2,688 shares) and 3/21/2010 (2,688 shares).